Starling Oncology (STLN) Free Cash Flow Growth (1y) (2021 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) Free Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | -63.61% |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | -43.88% |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | -45.01% |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 57.65% |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | -23.78% |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | 12.24% |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | -43.57% |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | -8.16% |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | 89.29% |
| 10 | Starling Oncology | 609.95 Mn | 568.85 Mn | 27.17 Mn | 196.69% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 196.69% |
| Mar 31, 2026 | 38.73% |
| Dec 31, 2025 | -3.21% |
| Sep 30, 2025 | -1,183.87% |
| Jun 30, 2025 | 34.75% |
| Mar 31, 2025 | 67.77% |
| Dec 31, 2024 | 147.22% |
| Sep 30, 2024 | 113.21% |
| Jun 30, 2024 | -82.20% |
| Mar 31, 2024 | 4.62% |
| Dec 31, 2023 | 70.27% |
| Sep 30, 2023 | 57.20% |
| Jun 30, 2023 | 18.12% |
| Mar 31, 2023 | 3.85% |
| Dec 31, 2022 | 33.93% |
| Sep 30, 2022 | -494.90% |
| Jun 30, 2022 | -55.51% |
| Mar 31, 2022 | -11,501.94% |
| Dec 31, 2021 | -2,499.14% |
| Sep 30, 2021 | -5,127.68% |